Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Irfan Manji, Sarah Wells, Vanina Dal Bello-Haas & Pascal Fallavollita. (2023) Impact of dance interventions on the symptoms of dementia: A mixed-methods systematic review. Arts & Health 0:0, pages 1-25.
Read now
Read now
Susan Aguiñaga, Jacqueline Guzman, Yuliana Soto & David X. Marquez. (2023) Self-rated health as a predictor of cognition among middle-aged and older Latinos. Aging, Neuropsychology, and Cognition 30:3, pages 388-401.
Read now
Read now
Sajay Arthanat, John Wilcox & Dain LaRoche. (2022) Smart home automation technology to support caring of individuals with Alzheimer’s disease and related dementia: an early intervention framework. Disability and Rehabilitation: Assistive Technology 0:0, pages 1-11.
Read now
Read now
Roshanak Mehdipanah, Emily M. Briceño, Xavier F. Gonzales, Steven G. Heeringa, Deborah A. Levine, Kenneth M. Langa, Nelda Garcia, Ruth Longoria & Lewis B. Morgenstern. (2022) Dementia care needs for individuals and caregivers among Mexican Americans and non-Hispanic Whites. Aging & Mental Health 26:8, pages 1630-1641.
Read now
Read now
Yahan Zhang, Jiang Bian, Jinhai Huo, Shuang Yang, Yi Guo & Hui Shao. (2021) Comparing the downstream costs and healthcare utilization associated with the use of low-dose computed tomography (LDCT) in lung cancer screening in patients with and without alzheimer’s disease and related dementias (ADRD). Current Medical Research and Opinion 37:10, pages 1731-1737.
Read now
Read now
Hongdao Meng, Victoria R. Marino, Kyaien O. Conner, Dinesh Sharma, W. Shuford Davis & Robert L. Glueckauf. (2021) Effects of in-person and telephone-based cognitive behavioral therapies on health services use and expenditures among African-American dementia caregivers with depressive symptoms. Ethnicity & Health 26:6, pages 879-892.
Read now
Read now
Anders Gustavsson, Peter Pemberton-Ross, Melissa Gomez Montero, Mahmoud Hashim & Robin Thompson. (2020) Challenges in demonstrating the value of disease-modifying therapies for Alzheimer’s disease. Expert Review of Pharmacoeconomics & Outcomes Research 20:6, pages 563-570.
Read now
Read now
Susan M. McLennon, Joel G. Anderson, Fayron Epps & Karen M. Rose. (2020) “It’s just part of life”: African American daughters caring for parents with dementia. Journal of Women & Aging 32:2, pages 168-182.
Read now
Read now
Articles from other publishers (91)
Dawei Guan, Motomori O. Lewis, Piaopiao Li, Yichen Zhang, Ping Zhang, Shichao Tang, Joshua Brown, Jingchuan Guo, Yongkang Zhang & Hui Shao. (2023) Incremental burden on health‐related quality of life, health service utilization and direct medical expenditures associated with cognitive impairment among non‐institutionalized people with diabetes aged 65 years and older. Diabetes, Obesity and Metabolism 26:1, pages 275-282.
Crossref
Crossref
Yunjiao Mao, Yue Li, Brian McGarry, Jinjiao Wang & Helena Temkin‐Greener. (2023) Home time and state regulations among Medicare beneficiaries in assisted living communities. Journal of the American Geriatrics Society.
Crossref
Crossref
Nan Wang, Hanzhang Xu, Jessica S. West, Truls Østbye, Bei Wu, Ying Xian & Matthew E. Dupre. (2023) Association between perceived risk of Alzheimer's disease and related dementias and cognitive function among U.S. older adults. Archives of Gerontology and Geriatrics 115, pages 105126.
Crossref
Crossref
Jing Li, Hannah Bancroft, Krista L. Harrison, Julia Fox, Ana M. Tyler & Jalayne J. Arias. (2023) Out-of-Pocket Expenses for Long-Term Care by Dementia Status and Residential Setting among US Older Adults. Journal of the American Medical Directors Association.
Crossref
Crossref
Yuyan Guo, Ruifeng Liang, Jingjuan Ren, Liting Cheng, Mengqin Wang, Huilin Chai, Xiaoyu Cheng, Yaowen Yang, Yajuan Sun, Jiantao Li, Shuhong Zhao, Wenjing Hou, Jianhua Zhang, Feng Liu, Rong Wang, Qiao Niu, Hongmei Yu, Shoulin Yang, Jianying Bai, Hongmei Zhang, Xiaojiang Qin & Na Xia. (2023) Cognitive status and its risk factors in patients with hypertension and diabetes in a low‐income rural area of China: A cross‐sectional study. International Journal of Geriatric Psychiatry 38:10.
Crossref
Crossref
Maryam Zolnoori, Yolanda Barrón, Jiyoun Song, James Noble, Julia Burgdorf, Miriam Ryvicker & Maxim Topaz. (2023) HomeADScreen: Developing Alzheimer's disease and related dementia risk identification model in home healthcare. International Journal of Medical Informatics 177, pages 105146.
Crossref
Crossref
Ella R. Lenox & Michael W. Jones. (2023) Balance-Based Exercise Programs on Balance in Older Adults with Mild to Moderate Dementia: A Critically Appraised Topic. Ageing Research Reviews, pages 102073.
Crossref
Crossref
Sanjna Vinze, Joshua Chodosh, Matthew Lee, Jacob Wright & Soo Borson. (2023) The national public health response to Alzheimer's disease and related dementias: Origins, evolution, and recommendations to improve early detection. Alzheimer's & Dementia 19:9, pages 4276-4286.
Crossref
Crossref
Jeffrey Cummings, Julie Hviid Hahn-Pedersen, Christian Stefan Eichinger, Caroline Freeman, Alice Clark, Luis Rafael Solís Tarazona & Krista Lanctôt. (2023) Exploring the relationship between patient-relevant outcomes and Alzheimer’s disease progression assessed using the clinical dementia rating scale: a systematic literature review. Frontiers in Neurology 14.
Crossref
Crossref
Ila Hughes Broyles, Qinghua Li, Lauren Martin Palmer, Michael DiBello, Judith Dey, Iara Oliveira & Helen Lamont. (2023) Dementia’s Unique Burden: Function and Health Care in the Last 4 Years of Life. The Journals of Gerontology: Series A 78:6, pages 1053-1059.
Crossref
Crossref
Tammy T. Hshieh, Ray Yun Gou, Richard N. Jones, Douglas L. Leslie, Edward R. Marcantonio, Guoquan Xu, Thomas G. Travison, Tamara G. Fong, Eva M. Schmitt & Sharon K. Inouye. (2022) One‐year Medicare costs associated with delirium in older hospitalized patients with and without Alzheimer's disease dementia and related disorders. Alzheimer's & Dementia 19:5, pages 1901-1912.
Crossref
Crossref
Alette M. WesselsEllen B. DennehySherie A. DowsettSamuel P. DicksonSuzanne B. Hendrix. (2023) Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings. Neurology Clinical Practice 13:2.
Crossref
Crossref
. (2023) 2023 Alzheimer's disease facts and figures. Alzheimer's & Dementia 19:4, pages 1598-1695.
Crossref
Crossref
Phyllis B. Ferrell, Howard Fillit, Peter J. Neumann, J. K. Wall & James F. Murray. (2022) Toward comprehensive value assessment for Alzheimer's disease innovations. Alzheimer's & Dementia 19:4, pages 1558-1567.
Crossref
Crossref
Hans J. Moebius & Kevin J. Church. (2023) The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators. Journal of Alzheimer's Disease 92:1, pages 1-12.
Crossref
Crossref
George Dranitsaris, Quanwu Zhang, Alex Quill, Lin Mu, Christopher Weyrer, Erik Dysdale, Peter Neumann & Amir Abbas Tahami Monfared. (2022) Treatment Preference for Alzheimer’s Disease: A Multicriteria Decision Analysis with Caregivers, Neurologists, and Payors. Neurology and Therapy 12:1, pages 211-227.
Crossref
Crossref
Anish Kapadia, Krish BillimoriaPrarthna Desai, James T. Grist, Chris Heyn, Pejman Maralani, Sean Symons & Fulvio Zaccagna. (2023) Hypoperfusion Precedes Tau Deposition in the Entorhinal Cortex: A Retrospective Evaluation of ADNI-2 Data. Journal of Clinical Neurology 19:2, pages 131.
Crossref
Crossref
Keith R. Thulborn. 2023. Functional Neuroradiology. Functional Neuroradiology
1239
1258
.
Tanya G. K. Bentley, Daisy Castillo, Nina Sadeghi, Dominique Piber, Judith Carroll, Richard Olmstead & Michael R. Irwin. (2022) Costs associated with treatment of insomnia in Alzheimer’s disease caregivers: a comparison of mindfulness meditation and cognitive behavioral therapy for insomnia. BMC Health Services Research 22:1.
Crossref
Crossref
Yuzi Zhang, Stefanie T. Ebelt, Liuhua Shi, Noah C. Scovronick, Rohan R. D'Souza, Kyle Steenland & Howard H. Chang. (2022) Short-term associations between warm-season ambient temperature and emergency department visits for Alzheimer's disease and related dementia in five US states. Environmental Research, pages 115176.
Crossref
Crossref
Roshanak Mehdipanah, Emily M. Briceño, Steven G. Heeringa, Xavier F. Gonzales, Deborah A. Levine, Kenneth M. Langa, Nelda Garcia, Ruth Longoria, Wen Chang & Lewis B. Morgenstern. (2022) Neighborhood SES and Cognitive Function Among Hispanic/Latinx Residents: Why Where You Live Matters. American Journal of Preventive Medicine 63:4, pages 574-581.
Crossref
Crossref
Amir Abbas Tahami Monfared, Yaakov Stern, Stephen Doogan, Michael Irizarry & Quanwu Zhang. (2022) Stakeholder Insights in Alzheimer’s Disease: Natural Language Processing of Social Media Conversations. Journal of Alzheimer's Disease 89:2, pages 695-708.
Crossref
Crossref
Livia La Barbera, Emanuele Mauri, Marcello D’Amelio & Manuele Gori. (2022) Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives. Frontiers in Neuroscience 16.
Crossref
Crossref
Douglas L. Leslie, Donna M. Fick, Amber Moore, Sharon K. Inouye, Yoojin Jung, Long H. Ngo, Marie Boltz, Erica Husser, Priyanka Shrestha, Malaz Boustani & Edward R. Marcantonio. (2022)
Comparative
salary‐related
costs of a brief app‐directed delirium identification protocol by hospitalists, nurses, and nursing assistants
. Journal of the American Geriatrics Society 70:8, pages 2371-2378.
Crossref
Crossref
Alette M. Wessels, Mark Belger, Joseph A. Johnston, Youying Yu, Dorene M. Rentz, Sherie A. Dowsett & Julie Chandler. (2022) Demonstration of Clinical Meaningfulness of the Integrated Alzheimer’s Disease Rating Scale (iADRS): Association Between Change in iADRS Scores and Patient and Caregiver Health Outcomes. Journal of Alzheimer's Disease 88:2, pages 577-588.
Crossref
Crossref
Yi-Shao Liu, Jamie C. Barner, Karen L. Rascati & Sandipan Bhattacharjee. (2022) Economic Burden of Chronic Comorbidities Among Community-Dwelling Older Adults With Dementia. Alzheimer Disease & Associated Disorders 36:3, pages 244-252.
Crossref
Crossref
Michael D. Osterman, Yeunjoo E. Song, Larry D. Adams, Renee A. Laux, Laura J. Caywood, Michael B. Prough, Jason E. Clouse, Sharlene D. Herington, Susan H. Slifer, Audrey Lynn, M. Denise Fuzzell, Sarada L. Fuzzell, Sherri D. Hochstetler, Kristy Miskimen, Leighanne R. Main, Daniel A. Dorfsman, Paula Ogrocki, Alan J. Lerner, Jairo Ramos, Jeffery M. Vance, Michael L. Cuccaro, William K. Scott, Margaret A. Pericak-Vance & Jonathan L. Haines. (2022) The genetic architecture of Alzheimer disease risk in the Ohio and Indiana Amish. Human Genetics and Genomics Advances 3:3, pages 100114.
Crossref
Crossref
Siti Maisarah Mattap, Devi Mohan, Andrea Mary McGrattan, Pascale Allotey, Blossom CM Stephan, Daniel D Reidpath, Mario Siervo, Louise Robinson & Nathorn Chaiyakunapruk. (2022) The economic burden of dementia in low- and middle-income countries (LMICs): a systematic review. BMJ Global Health 7:4, pages e007409.
Crossref
Crossref
. (2022) 2022 Alzheimer's disease facts and figures. Alzheimer's & Dementia 18:4, pages 700-789.
Crossref
Crossref
Pragati Katiyar, Armineh L. Ghazarian, Zane Martin & Todd Haim. 2022. Alzheimer's Disease Drug Development. Alzheimer's Disease Drug Development
533
543
.
Nazia Rashid, James B. Wetmore, Muna Irfan & Victor Abler. (2022) Economic Evaluation of Healthcare Resource Utilization and Costs for Newly Diagnosed Dementia-Related Psychosis. Geriatrics 7:2, pages 29.
Crossref
Crossref
Steven A. Cohen, Neelam Ahmed, Monique J. Brown, Marissa R. Meucci & Mary L. Greaney. (2021) Rural‐urban differences in informal caregiving and health‐related quality of life. The Journal of Rural Health 38:2, pages 442-456.
Crossref
Crossref
Armineh L Ghazarian, Todd Haim, Samir Sauma & Pragati Katiyar. (2021) National Institute on Aging seed funding enables Alzheimer's disease startups to reach key value inflection points. Alzheimer's & Dementia 18:2, pages 348-359.
Crossref
Crossref
Susanna S. Kwok, Xuan-Mai T. Nguyen, Diana D. Wu, Raksha A. Mudar & Daniel A. Llano. (2022) Pure Tone Audiometry and Hearing Loss in Alzheimer's Disease: A Meta-Analysis. Frontiers in Psychology 12.
Crossref
Crossref
Manuel Ruiz-Adame. (2022) A Systematic Review of the Indirect and Social Costs in Early and Young Onset Dementias. Journal of Alzheimer's Disease 85:1, pages 21-29.
Crossref
Crossref
Laura T Pizzi, Eric Jutkowitz, Katherine M Prioli, Ember (Yiwei) Lu, Zachary Babcock, Heather McAbee-Sevick, Dorothy B Wakefield, Julie Robison, Sheila Molony, Catherine V Piersol, Laura N Gitlin & Richard H Fortinsky. (2022) Cost–Benefit Analysis of the COPE Program for Persons Living With Dementia: Toward a Payment Model. Innovation in Aging 6:1.
Crossref
Crossref
Mary L. Davis-Ajami, Zhiqiang K. Lu & Jun Wu. (2022) Exploring the home healthcare workforce in Alzheimer's disease and related dementias: Utilization and cost outcomes in US community dwelling older adults. Archives of Gerontology and Geriatrics 98, pages 104536.
Crossref
Crossref
Wei Zhang & Huiying Sun. (2021) How to analyze work productivity loss due to health problems in randomized controlled trials? A simulation study. BMC Medical Research Methodology 21:1.
Crossref
Crossref
Minal R. PatelReshma JagsiKenneth ResnicowShawna N. SmithLauren M. HamelChristopher SuJennifer J. GriggsDiamond BuchananNicole IsaacsonMichelle Torby. (2021) A Scoping Review of Behavioral Interventions Addressing Medical Financial Hardship. Population Health Management 24:6, pages 710-721.
Crossref
Crossref
William L. Herring, Ian Gopal Gould, Howard Fillit, Peter Lindgren, Fiona Forrestal, Robin Thompson & Peter Pemberton-Ross. (2021) Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer’s Disease. Neurology and Therapy 10:2, pages 919-940.
Crossref
Crossref
Marc Fakhoury, Fabrizio Piras & Nerisa Banaj. (2021) Editorial: Alzheimer's Disease From a Psychiatric Perspective: Towards New Therapeutic Guidelines?. Frontiers in Psychiatry 12.
Crossref
Crossref
Heather Ma, Rachel E. Kiekhofer, Sarah M. Hooper, Sarah Dulaney, Katherine L. Possin & Winston Chiong. (2021) Goals of Care Conversations and Subsequent Advance Care Planning Outcomes for People with Dementia. Journal of Alzheimer's Disease 83:4, pages 1767-1773.
Crossref
Crossref
Zaina P. Qureshi, Ellen Thiel, James Nelson & Rezaul Khandker. (2021) Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer’s Disease Patients. Journal of Alzheimer's Disease 83:4, pages 1679-1690.
Crossref
Crossref
T. Joseph MattinglyIIII, R. Brett McQueen & Pei-Jung Lin. (2021) Contextual Considerations and Recommendations for Estimating the Value of Alzheimer’s Disease Therapies. PharmacoEconomics 39:10, pages 1101-1107.
Crossref
Crossref
Gail A. Stonebarger, Heather A. Bimonte-Nelson & Henryk F. Urbanski. (2021) The Rhesus Macaque as a Translational Model for Neurodegeneration and Alzheimer’s Disease. Frontiers in Aging Neuroscience 13.
Crossref
Crossref
ShannonB. Juengst, Charlene Supnet, Chung Lin (Novelle) Kew, Valeria Silva, Marlene Vega, Gang Han, Brendan Kelley, Matthew Lee Smith & Gladys Maestre. (2021) Bilingual problem-solving training for caregivers of adults with dementia: A randomized, factorial-design protocol for the CaDeS trial. Contemporary Clinical Trials 108, pages 106506.
Crossref
Crossref
Z. Kevin Lu, Xiaomo Xiong, Xinyuan Wang & Jun Wu. (2021) Gender Disparities in Anti-dementia Medication Use among Older Adults: Health Equity Considerations and Management of Alzheimer's Disease and Related Dementias. Frontiers in Pharmacology 12.
Crossref
Crossref
Marleigh Hefner, Vineet Baliga, Kailinn Amphay, Daniela Ramos & Vijay Hegde. (2021) Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology. Frontiers in Aging Neuroscience 13.
Crossref
Crossref
Joseph M. Schulz. (2021) The Potential of Induced Pluripotent Stem Cells to Treat and Model Alzheimer’s Disease. Stem Cells International 2021, pages 1-16.
Crossref
Crossref
Lydia Neubert, Hans-Helmut König, Claudia Mietzner & Christian Brettschneider. (2019) Dementia care-giving and employment: a mixed-studies review on a presumed conflict. Ageing and Society 41:5, pages 1094-1125.
Crossref
Crossref
. (2021)
2021
Alzheimer's disease facts and figures
. Alzheimer's & Dementia 17:3, pages 327-406.
Crossref
Crossref
Alexander Braun, Paulina Kurzmann, Margit Höfler, Gottfried Haber & Stefanie Auer. (2020) Cost of care for persons with dementia: using a discrete-time Markov chain approach with administrative and clinical data from the dementia service Centres in Austria. Health Economics Review 10:1.
Crossref
Crossref
GA Stonebarger, HF Urbanski, RL Woltjer, KL Vaughan, DK Ingram, PL Schultz, SM Calderazzo, JA Siedeman, JA Mattison, DL Rosene & SG Kohama. (2020) Amyloidosis increase is not attenuated by long-term calorie restriction or related to neuron density in the prefrontal cortex of extremely aged rhesus macaques. GeroScience 42:6, pages 1733-1749.
Crossref
Crossref
Oriol Turró-Garriga, Vanesa Viñas-Díez, Josep Lluís Conde-Sala, Laia Calvó-Perxas, Marta Cullell-Juncà, Glòria Mas-Vall-llosera, Margarida Flaqué, Antoni Turon-Estrada, Dolors Juvinyà-Canal, Eneida Mioshi & Josep Garre-Olmo. (2020) Caregivers’ Sense of Coherence: Implications on Direct and Indirect Costs of Dementia Care. Journal of Alzheimer's Disease 78:1, pages 117-126.
Crossref
Crossref
Mazel Mihardja, Jaydeep Roy, Kan Yin Wong, Luca Aquili, Boon Chin Heng, Ying‐Shing Chan, Man Lung Fung & Lee Wei Lim. (2020) Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease. Annals of the New York Academy of Sciences 1478:1, pages 43-62.
Crossref
Crossref
Michael Ugrumov. (2020) Development of early diagnosis of Parkinson's disease: Illusion or reality?. CNS Neuroscience & Therapeutics 26:10, pages 997-1009.
Crossref
Crossref
Paul A. Fishman, Lindsay White, Bailey Ingraham, Sungchul Park, Eric B. Larson, Paul Crane & Norma B. Coe. (2020) Health Care Costs of Alzheimer’s and Related Dementias Within a Medicare Managed Care Provider. Medical Care 58:9, pages 833-841.
Crossref
Crossref
Romain Goulay, Luis Mena Romo, Elly M. Hol & Rick M. Dijkhuizen. (2019) From Stroke to Dementia: a Comprehensive Review Exposing Tight Interactions Between Stroke and Amyloid-β Formation. Translational Stroke Research 11:4, pages 601-614.
Crossref
Crossref
Kathrin Steinbeisser, Larissa Schwarzkopf, Elmar Graessel & Hildegard Seidl. (2020) Cost-effectiveness of a non-pharmacological treatment vs. “care as usual” in day care centers for community-dwelling older people with cognitive impairment: results from the German randomized controlled DeTaMAKS-trial. The European Journal of Health Economics 21:6, pages 825-844.
Crossref
Crossref
Nadia M. Chu, Zhan Shi, Christine E. Haugen, Silas P. Norman, Alden L. Gross, Daniel C. Brennan, Michelle C. Carlson, Dorry L. Segev & Mara A. McAdams-DeMarco. (2020) Cognitive Function, Access to Kidney Transplantation, and Waitlist Mortality Among Kidney Transplant Candidates With or Without Diabetes. American Journal of Kidney Diseases 76:1, pages 72-81.
Crossref
Crossref
Shiori Tomita, Eri Hoshino, Keisuke Kamiya, Osugi Yasuhiro & Mahbubur Rahman. (2020) Direct and indirect costs of home healthcare in Japan: A cross‐sectional study. Health & Social Care in the Community 28:3, pages 1109-1117.
Crossref
Crossref
. (2020) 2020 Alzheimer's disease facts and figures. Alzheimer's & Dementia 16:3, pages 391-460.
Crossref
Crossref
Petra Marešová, Josef Dolejs, Hana Mohelska & Laura K. Bryan. (2020) Cost of Treatment and Care for People with Alzheimer’s Disease: A Meta- Analysis. Current Alzheimer Research 16:14, pages 1245-1253.
Crossref
Crossref
Timothy Thoits, Janani Sadasivan, Jessica L Parker & Nicholas J Andersen. (2020) Acute Healthcare Utilization of a Multidisciplinary Neurocognitive Dementia Patient Cohort. Journal of Clinical Neurology 16:3, pages 433.
Crossref
Crossref
Walia Zahra, Sachchida Nand Rai, Hareram Birla, Saumitra Sen Singh, Hagera Dilnashin, Aaina Singh Rathore & Surya Pratap Singh. 2020. Bioeconomy for Sustainable Development. Bioeconomy for Sustainable Development
333
345
.
Yat-Fung Shea & Steven T. DeKosky. 2019. Cognitive Changes and the Aging Brain. Cognitive Changes and the Aging Brain
291
306
.
Dasa Bohaciakova, Marian Hruska-Plochan, Rachel Tsunemoto, Wesley D. Gifford, Shawn P. Driscoll, Thomas D. Glenn, Stephanie Wu, Silvia Marsala, Michael Navarro, Takahiro Tadokoro, Stefan Juhas, Jana Juhasova, Oleksandr Platoshyn, David Piper, Vickie Sheckler, Dara Ditsworth, Samuel L. Pfaff & Martin Marsala. (2019) A scalable solution for isolating human multipotent clinical-grade neural stem cells from ES precursors. Stem Cell Research & Therapy 10:1.
Crossref
Crossref
Pallavi Sood, Sandra L Kletzel, Shilpa Krishnan, Hannes Devos, Ahmed Negm, Lilian Hoffecker, Joseph Machtinger, Xiaolei Hu & Patricia C Heyn. (2019) Nonimmersive Brain Gaming for Older Adults With Cognitive Impairment: A Scoping Review. The Gerontologist 59:6, pages e764-e781.
Crossref
Crossref
Changtae Hahn & Chang Uk Lee. (2019) A Brief Review of Paradigm Shifts in Prevention of Alzheimer’s Disease: From Cognitive Reserve to Precision Medicine. Frontiers in Psychiatry 10.
Crossref
Crossref
M. Ikram, K. Innes & U. Sambamoorthi. (2019) Association of osteoarthritis and pain with Alzheimer's Diseases and Related Dementias among older adults in the United States. Osteoarthritis and Cartilage 27:10, pages 1470-1480.
Crossref
Crossref
Chia-Hsiung Cheng, Kun-Ju Lin, Chien-Tai Hong, Dean Wu, Hung-Ming Chang, Cheng-Huan Liu, Ing-Tsung Hsiao, Chih-Ping Yang, Yu-Chuan Liu & Chaur-Jong Hu. (2019) Plasmon-Activated Water Reduces Amyloid Burden and Improves
Memory in Animals with Alzheimer’s Disease. Scientific Reports 9:1.
Crossref
Crossref
Roberta Marongiu. (2019) Accelerated Ovarian Failure as a Unique Model to Study Peri-Menopause Influence on Alzheimer’s Disease. Frontiers in Aging Neuroscience 11.
Crossref
Crossref
Aaron Gilson, Debby Dodds, Arveen Kaur, Michael Potteiger & James H Ford II. (2019) Using Computer Tablets to Improve Moods for Older Adults With Dementia and Interactions With Their Caregivers: Pilot Intervention Study. JMIR Formative Research 3:3, pages e14530.
Crossref
Crossref
Steven A. Cohen, Natalie J. Sabik, Sarah K. Cook, Ariana B. Azzoli & Carolyn A. Mendez-Luck. (2019) Differences within Differences: Gender Inequalities in Caregiving Intensity Vary by Race and Ethnicity in Informal Caregivers. Journal of Cross-Cultural Gerontology 34:3, pages 245-263.
Crossref
Crossref
Maoxue Tang, Sarah H. Park, Darryl C. De Vivo & Umrao R. Monani. (2019) Therapeutic strategies for glucose transporter 1 deficiency syndrome. Annals of Clinical and Translational Neurology 6:9, pages 1923-1932.
Crossref
Crossref
Youssef H. El-Hayek, Ryan E. Wiley, Charles P. Khoury, Ritesh P. Daya, Clive Ballard, Alison R. Evans, Michael Karran, José Luis Molinuevo, Matthew Norton & Alireza Atri. (2019) Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer’s Disease and Related Dementias and Strategic Implications for Stakeholders. Journal of Alzheimer's Disease 70:2, pages 323-341.
Crossref
Crossref
Paula Domenech-Cebrían, Mary Martinez-Martinez & Omar Cauli. (2019) Relationship between mobility and cognitive impairment in patients with Alzheimer’s disease. Clinical Neurology and Neurosurgery 179, pages 23-29.
Crossref
Crossref
. (2019) 2019 Alzheimer's disease facts and figures. Alzheimer's & Dementia 15:3, pages 321-387.
Crossref
Crossref
Péter Hudomiet, Michael D. Hurd & Susann Rohwedder. (2019) The relationship between lifetime out-of-pocket medical expenditures, dementia, and socioeconomic status in the U.S. The Journal of the Economics of Ageing 14, pages 100181.
Crossref
Crossref
Heiko Braak & Kelly Del Tredici. 2019. Tau Biology. Tau Biology
291
303
.
Tian Li, Huangan Wu, Franscisca Soto-Aguliar, Li Huang, Wentao Li, Lixing Lao & Shifen Xu. (2018) Efficacy of electrical acupuncture on vascular cognitive impairment with no dementia: study protocol for a randomized controlled trial. Trials 19:1.
Crossref
Crossref
Kevin Mullane & Michael Williams. (2018) Alzheimer’s disease (AD) therapeutics – 2: Beyond amyloid – Re-defining AD and its causality to discover effective therapeutics. Biochemical Pharmacology 158, pages 376-401.
Crossref
Crossref
Kevin Mullane & Michael Williams. (2018) Alzheimer’s disease (AD) therapeutics – 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality. Biochemical Pharmacology 158, pages 359-375.
Crossref
Crossref
Mark A. McCormickDaniel E.L. Promislow. (2018) Recent Advances in the Systems Biology of Aging. Antioxidants & Redox Signaling 29:10, pages 973-984.
Crossref
Crossref
Hui Yang, Hongcai Wang, Yongwei Shu & Xuling Li. (2018) miR-103 Promotes Neurite Outgrowth and Suppresses Cells Apoptosis by Targeting Prostaglandin-Endoperoxide Synthase 2 in Cellular Models of Alzheimer’s Disease. Frontiers in Cellular Neuroscience 12.
Crossref
Crossref
Jalayne J. Arias, Ana M. Tyler, Benjamin J. Oster & Jason Karlawish. (2021) The Proactive Patient: Long-Term Care Insurance Discrimination Risks of Alzheimer's Disease Biomarkers. Journal of Law, Medicine & Ethics 46:2, pages 485-498.
Crossref
Crossref
Jeffrey Cummings, Carl Reiber & Parvesh Kumar. (2018) The price of progress: Funding and financing Alzheimer's disease drug development. Alzheimer's & Dementia: Translational Research & Clinical Interventions 4:1, pages 330-343.
Crossref
Crossref
Pablo Martínez-Lage, Manuel Martín-Carrasco, Enrique Arrieta, Jesús Rodrigo & Francesc Formiga. (2018) Mapa de la enfermedad de Alzheimer y otras demencias en España. Proyecto MapEA. Revista Española de Geriatría y Gerontología 53:1, pages 26-37.
Crossref
Crossref
Junfang Xu & Chengxuan Qiu. 2018. Biomarkers for Preclinical Alzheimer’s Disease. Biomarkers for Preclinical Alzheimer’s Disease
3
13
.
Roderick A. CorriveauWalter J. KoroshetzJordan T. GladmanSophia JeonDebra BabcockDavid A. BennettS. Thomas CarmichaelSusan L.-J. DickinsonDennis W. DicksonMarian EmrHoward FillitSteven M. GreenbergMichael L. HuttonDavid S. KnopmanJennifer J. ManlyKaren S. MarderClaudia S. MoyCreighton H. PhelpsPaul A. ScottWilliam W. SeeleyBeth-Anne SieberNina B. SilverbergMargaret L. SutherlandAngela TaylorChristine L. TorborgSalina P. WaddyAmelie K. GubitzDavid M. Holtzman. (2017) Alzheimer's Disease–Related Dementias Summit 2016: National research priorities. Neurology 89:23, pages 2381-2391.
Crossref
Crossref
Edward R. Blonz. (2017) Alzheimer’s Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis. Journal of Alzheimer's Disease 60:4, pages 1223-1229.
Crossref
Crossref